Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer

Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer

Prostate cancer is the second most common malignancy in men worldwide. Prostate cancer can be treated by surgery, radiotherapy and hormone therapy. The latter, in the form of androgen-deprivation therapy is needed to reduce prostate cancer progression at an advanced stage. Several studies demonstrat...

Full description

Bibliographic Details
Main Authors: Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, Roberta Mazzucchelli
Format: Article
Language:English
Published: IMR Press 2023-07-01
Series:Frontiers in Bioscience-Landmark
Subjects:
nrf2
chemotherapy
prostate cancer
signaling
keap
antioxidants
modulator
Online Access:https://www.imrpress.com/journal/FBL/28/7/10.31083/j.fbl2807143

Internet

https://www.imrpress.com/journal/FBL/28/7/10.31083/j.fbl2807143

Similar Items